| Product Code: ETC12320142 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Hormone Refractory Prostate Cancer Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Hormone Refractory Prostate Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 India Hormone Refractory Prostate Cancer Market - Industry Life Cycle |
3.4 India Hormone Refractory Prostate Cancer Market - Porter's Five Forces |
3.5 India Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
3.6 India Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 India Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Hormone Refractory Prostate Cancer Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Hormone Refractory Prostate Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of prostate cancer in India |
4.2.2 Growing awareness about advanced treatment options for hormone refractory prostate cancer |
4.2.3 Rising investments in healthcare infrastructure and research and development activities in India |
4.3 Market Restraints |
4.3.1 High cost of advanced treatment options for hormone refractory prostate cancer |
4.3.2 Limited access to specialized healthcare services in certain regions of India |
4.3.3 Stringent regulatory requirements for approval of new treatments in India |
5 India Hormone Refractory Prostate Cancer Market Trends |
6 India Hormone Refractory Prostate Cancer Market, By Types |
6.1 India Hormone Refractory Prostate Cancer Market, By Cancer Stage |
6.1.1 Overview and Analysis |
6.1.2 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Cancer Stage, 2021 - 2031F |
6.1.3 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Castration-resistant Prostate Cancer, 2021 - 2031F |
6.1.4 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Metastatic Hormone-refractory Cancer, 2021 - 2031F |
6.1.5 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Non-metastatic Hormone-refractory Cancer, 2021 - 2031F |
6.1.6 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Recurrent Prostate Cancer, 2021 - 2031F |
6.2 India Hormone Refractory Prostate Cancer Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.4 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Androgen Receptor Inhibitors, 2021 - 2031F |
6.2.5 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Radioisotope Therapy, 2021 - 2031F |
6.3 India Hormone Refractory Prostate Cancer Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Men Aged 50+, 2021 - 2031F |
6.3.3 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.3.4 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Urology Clinics, 2021 - 2031F |
6.3.5 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Cancer Research Institutes, 2021 - 2031F |
6.4 India Hormone Refractory Prostate Cancer Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Late-stage Cancer Treatment, 2021 - 2031F |
6.4.3 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Advanced Prostate Cancer Care, 2021 - 2031F |
6.4.4 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Localized Prostate Cancer, 2021 - 2031F |
6.4.5 India Hormone Refractory Prostate Cancer Market Revenues & Volume, By Precision Oncology, 2021 - 2031F |
7 India Hormone Refractory Prostate Cancer Market Import-Export Trade Statistics |
7.1 India Hormone Refractory Prostate Cancer Market Export to Major Countries |
7.2 India Hormone Refractory Prostate Cancer Market Imports from Major Countries |
8 India Hormone Refractory Prostate Cancer Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rate of new treatment modalities |
8.3 Number of clinical trials conducted for hormone refractory prostate cancer in India |
9 India Hormone Refractory Prostate Cancer Market - Opportunity Assessment |
9.1 India Hormone Refractory Prostate Cancer Market Opportunity Assessment, By Cancer Stage, 2021 & 2031F |
9.2 India Hormone Refractory Prostate Cancer Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 India Hormone Refractory Prostate Cancer Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Hormone Refractory Prostate Cancer Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Hormone Refractory Prostate Cancer Market - Competitive Landscape |
10.1 India Hormone Refractory Prostate Cancer Market Revenue Share, By Companies, 2024 |
10.2 India Hormone Refractory Prostate Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here